Find Cetraxate manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

CEP/COS

CEP/COS Certifications

0

EU WC

EU WC

0

KDMF

KDMF

0

NDC API

NDC API

0

VMF

NDC API

0

Listed Suppliers

Other Suppliers

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

FINISHED DOSAGE FORMULATIONS

0

FDF Dossiers

FDF Dossiers

0

FDA Orange Book

FDA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

0 DRUGS IN DEVELOPMENT

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

API REF. PRICE (USD/KG)

$
$ 0

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Regulatory FDF Prices

NA

API/FDF Prices: Book a Demo to
explore the features and consider
upgrading later

MARKET PLACE

0

API

0

FDF

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

0

News #PharmaBuzz

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 27724-96-5, Cetraxate, hydrochloride, Cetraxate hcl, Neuer, Dv-1006, Cetraxate (hydrochloride)
Molecular Formula
C17H24ClNO4
Molecular Weight
341.8  g/mol
InChI Key
USROQQUKEBHOFF-UHFFFAOYSA-N
FDA UNII
08IT6P8VHY

Cetraxate
1 2D Structure

Cetraxate

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
3-[4-[4-(aminomethyl)cyclohexanecarbonyl]oxyphenyl]propanoic acid;hydrochloride
2.1.2 InChI
InChI=1S/C17H23NO4.ClH/c18-11-13-1-6-14(7-2-13)17(21)22-15-8-3-12(4-9-15)5-10-16(19)20;/h3-4,8-9,13-14H,1-2,5-7,10-11,18H2,(H,19,20);1H
2.1.3 InChI Key
USROQQUKEBHOFF-UHFFFAOYSA-N
2.1.4 Canonical SMILES
C1CC(CCC1CN)C(=O)OC2=CC=C(C=C2)CCC(=O)O.Cl
2.2 Other Identifiers
2.2.1 UNII
08IT6P8VHY
2.3 Synonyms
2.3.1 MeSH Synonyms

1. 4-(2-carboxyethyl)phenyl-trans-4-aminomethylcyclohexane Carboxylate Hydrochloride

2. Cetraxate

3. Cetraxate Hydrochloride, (trans)-isomer

4. Dv 1006

2.3.2 Depositor-Supplied Synonyms

1. 27724-96-5

2. Cetraxate, Hydrochloride

3. Cetraxate Hcl

4. Neuer

5. Dv-1006

6. Cetraxate (hydrochloride)

7. Dv1006

8. Dv 1006

9. 08it6p8vhy

10. 4'-(2-carboxyethyl)phenyl-trans-4-aminomethylcyclohexane Carboxylate Hydrochloride

11. Benzenepropanoic Acid, 4-(((4-(aminomethyl)cyclohexyl)carbonyl)oxy)-, Hydrochloride, Trans-

12. P-hydroxyhydrocinnamic Acid Trans-4-(aminomethyl)cyclohexanecarboxylate, Hydrochloride

13. 27724-96-5 (hcl)

14. Dsstox_cid_26459

15. Dsstox_rid_81633

16. Dsstox_gsid_46459

17. Mls001401399

18. Cetraxato Clorhidrato

19. Cas-27724-96-5

20. Cetraxato Clorhidrato [spanish]

21. Ncgc00164584-01

22. Cetraxate Hydrochloride [usan:jan]

23. Smr000469197

24. Unii-08it6p8vhy

25. Cetraxatehydrochloride

26. Neuer (tn)

27. 3-[4-[4-(aminomethyl)cyclohexanecarbonyl]oxyphenyl]propanoic Acid;hydrochloride

28. Schembl144285

29. Schembl144286

30. Chembl502896

31. Cetraxate Hydrochloridedv 1006

32. Dtxsid3046459

33. Phenyl)propanoic Acid Hydrochloride

34. Cetraxate Hydrochloride [mi]

35. Tox21_112210

36. Cetraxate Hydrochloride [jan]

37. Mfcd01722166

38. Cetraxate Hydrochloride [usan]

39. Akos025311449

40. Akos030239788

41. Cetraxate Hydrochloride (jp17/usan)

42. Tox21_112210_1

43. Ccg-100854

44. Cetraxate Hydrochloride [mart.]

45. Nc00104

46. Cetraxate Hydrochloride [who-dd]

47. Hydrocinnamic Acid, P-hydroxy-, 4-(aminomethyl)cyclohexanecarboxylate Hydrochloride, Trans-

48. Ncgc00164584-03

49. As-58253

50. Db-047265

51. Hy-122762

52. C3454

53. Cs-0088850

54. Ft-0602999

55. D02266

56. T70707

57. A819170

58. J-016867

59. Q27236401

60. 3-(4-((1r,4r)-4-(aminomethyl)cyclohexanecarbonyloxy)

61. 3-(4-((1r,4r)-4-(aminomethyl)cyclohexanecarbonyloxy)phenyl)propanoic Acid

62. 3-[4-[[4-(aminomethyl)cyclohexyl]-oxomethoxy]phenyl]propanoic Acid Hydrochloride

63. 3-[4-[[trans-4-(aminomethyl)cyclohexyl]carbonyloxy]phenyl]propanoic Acid Hydrochloride

64. 3-{4-[4-(aminomethyl)cyclohexanecarbonyloxy]phenyl}propanoic Acid Hydrochloride

2.4 Create Date
2005-06-24
3 Chemical and Physical Properties
Molecular Weight 341.8 g/mol
Molecular Formula C17H24ClNO4
Hydrogen Bond Donor Count3
Hydrogen Bond Acceptor Count5
Rotatable Bond Count7
Exact Mass341.1393859 g/mol
Monoisotopic Mass341.1393859 g/mol
Topological Polar Surface Area89.6 Ų
Heavy Atom Count23
Formal Charge0
Complexity369
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count2
4 Pharmacology and Biochemistry
4.1 MeSH Pharmacological Classification

Anti-Ulcer Agents

Various agents with different action mechanisms used to treat or ameliorate PEPTIC ULCER or irritation of the gastrointestinal tract. This has included ANTIBIOTICS to treat HELICOBACTER INFECTIONS; HISTAMINE H2 ANTAGONISTS to reduce GASTRIC ACID secretion; and ANTACIDS for symptomatic relief. (See all compounds classified as Anti-Ulcer Agents.)


ABOUT THIS PAGE

Looking for 27724-96-5 / Cetraxate API manufacturers, exporters & distributors?

Cetraxate manufacturers, exporters & distributors 1

89

PharmaCompass offers a list of Cetraxate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Cetraxate manufacturer or Cetraxate supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Cetraxate manufacturer or Cetraxate supplier.

PharmaCompass also assists you with knowing the Cetraxate API Price utilized in the formulation of products. Cetraxate API Price is not always fixed or binding as the Cetraxate Price is obtained through a variety of data sources. The Cetraxate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.

API | Excipient name

Cetraxate

Synonyms

27724-96-5, Cetraxate, hydrochloride, Cetraxate hcl, Neuer, Dv-1006, Cetraxate (hydrochloride)

Cas Number

27724-96-5

Unique Ingredient Identifier (UNII)

08IT6P8VHY

08IT6P8VHY Manufacturers

A 08IT6P8VHY manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of 08IT6P8VHY, including repackagers and relabelers. The FDA regulates 08IT6P8VHY manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. 08IT6P8VHY API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

08IT6P8VHY Suppliers

A 08IT6P8VHY supplier is an individual or a company that provides 08IT6P8VHY active pharmaceutical ingredient (API) or 08IT6P8VHY finished formulations upon request. The 08IT6P8VHY suppliers may include 08IT6P8VHY API manufacturers, exporters, distributors and traders.

click here to find a list of 08IT6P8VHY suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

08IT6P8VHY USDMF

A 08IT6P8VHY DMF (Drug Master File) is a document detailing the whole manufacturing process of 08IT6P8VHY active pharmaceutical ingredient (API) in detail. Different forms of 08IT6P8VHY DMFs exist exist since differing nations have different regulations, such as 08IT6P8VHY USDMF, ASMF (EDMF), JDMF, CDMF, etc.

A 08IT6P8VHY DMF submitted to regulatory agencies in the US is known as a USDMF. 08IT6P8VHY USDMF includes data on 08IT6P8VHY's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The 08IT6P8VHY USDMF is kept confidential to protect the manufacturer’s intellectual property.

click here to find a list of 08IT6P8VHY suppliers with USDMF on PharmaCompass.

08IT6P8VHY JDMF

The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.

The 08IT6P8VHY Drug Master File in Japan (08IT6P8VHY JDMF) empowers 08IT6P8VHY API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).

PMDA reviews the 08IT6P8VHY JDMF during the approval evaluation for pharmaceutical products. At the time of 08IT6P8VHY JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.

click here to find a list of 08IT6P8VHY suppliers with JDMF on PharmaCompass.

08IT6P8VHY GMP

08IT6P8VHY Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

PharmaCompass offers a list of 08IT6P8VHY GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right 08IT6P8VHY GMP manufacturer or 08IT6P8VHY GMP API supplier for your needs.

08IT6P8VHY CoA

A 08IT6P8VHY CoA (Certificate of Analysis) is a formal document that attests to 08IT6P8VHY's compliance with 08IT6P8VHY specifications and serves as a tool for batch-level quality control.

08IT6P8VHY CoA mostly includes findings from lab analyses of a specific batch. For each 08IT6P8VHY CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

08IT6P8VHY may be tested according to a variety of international standards, such as European Pharmacopoeia (08IT6P8VHY EP), 08IT6P8VHY JP (Japanese Pharmacopeia) and the US Pharmacopoeia (08IT6P8VHY USP).

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty